Ken Fisher Fisher Asset Management
AUM
$252B
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Quarter Return
+12.6%
1 Year Return
+19.67%
3 Year Return
+104.4%
5 Year Return
+153.45%
10 Year Return
+356.28%
AUM
$252B
AUM Growth
+$252B
(+9%)
Cap. Flow
-$2.39B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
30.76%
Holding
1,093
New
94
Increased
338
Reduced
521
Closed
107
Top Buys
| 1 |
Royal Bank of Canada
RY
|
$696M |
| 2 |
Sony
SONY
|
$424M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$402M |
| 4 |
SAP
SAP
|
$354M |
| 5 |
Spotify
SPOT
|
$353M |
Top Sells
| 1 |
Oracle
ORCL
|
$1.91B |
| 2 |
NVIDIA
NVDA
|
$1.3B |
| 3 |
Salesforce
CRM
|
$1.04B |
| 4 |
Eli Lilly
LLY
|
$886M |
| 5 |
JPMorgan Chase
JPM
|
$868M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Financials | 18.4% |
| 3 | Industrials | 9.35% |
| 4 | Healthcare | 9.18% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
HSBC
HSBC
$223B
| $1.04B | 0.41% | 17,043,371 +1,430,797 | +9% | +$87M |
|
77
Banco Santander
SAN
$142B
| $976M | 0.39% | 117,592,077 -10,751,133 | -8% | -$89.2M |
|
78
iShares National Muni Bond ETF
MUB
$38.7B
| $931M | 0.37% | 8,914,935 +2,679,139 | +43% | +$280M |
|
79
Illinois Tool Works
ITW
$77.1B
| $889M | 0.35% | 3,595,146 +80,527 | +2% | +$19.9M |
|
80
Trane Technologies
TT
$92.5B
| $874M | 0.35% | 1,998,440 -5,115 | -0.3% | -$2.24M |
|
81
Vanguard S&P 500 ETF
VOO
$725B
| $864M | 0.34% | 1,521,821 -9,306 | -0.6% | -$5.29M |
|
82
Novartis
NVS
$245B
| $862M | 0.34% | 7,121,414 +358,282 | +5% | +$43.4M |
|
83
Danaher
DHR
$147B
| $857M | 0.34% | 4,340,636 -294,492 | -6% | -$58.2M |
|
84
Boston Scientific
BSX
$156B
| $828M | 0.33% | 7,705,384 +939,834 | +14% | +$101M |
|
85
CSX Corp
CSX
$60.3B
| $825M | 0.33% | 25,272,260 +188,363 | +0.8% | +$6.15M |
|
86
Invesco QQQ Trust
QQQ
$369B
| $799M | 0.32% | 1,448,522 -68,582 | -5% | -$37.8M |
|
87
Novo Nordisk
NVO
$249B
| $759M | 0.3% | 11,000,916 -870,320 | -7% | -$60.1M |
|
|
88
Royal Bank of Canada
RY
$205B
| $753M | 0.3% | 5,723,581 +5,289,330 | +1,218% | +$696M |
|
89
Deutsche Bank
DB
$67.6B
| $746M | 0.3% | 25,471,401 +6,605,750 | +35% | +$193M |
|
90
AB InBev
BUD
$122B
| $733M | 0.29% | 10,663,933 +454,621 | +4% | +$31.2M |
|
91
Emerson Electric
EMR
$74.4B
| $692M | 0.27% | 5,193,448 +1,561,600 | +43% | +$208M |
|
92
Banco Bilbao Vizcaya Argentaria
BBVA
$104B
| $637M | 0.25% | 41,422,112 -2,179,615 | -5% | -$33.5M |
|
93
Sanofi
SNY
$120B
| $635M | 0.25% | 13,135,366 -430,963 | -3% | -$20.8M |
|
94
Lloyds Banking Group
LYG
$64.5B
| $633M | 0.25% | 148,828,623 +16,705,846 | +13% | +$71M |
|
95
Alibaba
BABA
$316B
| $597M | 0.24% | 5,267,441 +390,883 | +8% | +$44.3M |
|
96
iShares Global Healthcare ETF
IXJ
$3.8B
| $594M | 0.24% | 6,903,794 -390,064 | -5% | -$33.6M |
|
97
Ingersoll Rand
IR
$31.6B
| $575M | 0.23% | 6,913,924 +38,999 | +0.6% | +$3.24M |
|
98
Crown Castle
CCI
$42.7B
| $550M | 0.22% | 5,349,349 +90,165 | +2% | +$9.26M |
|
99
NatWest
NWG
$56.2B
| $531M | 0.21% | 37,531,392 +4,355,850 | +13% | +$61.6M |
|
100
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $529M | 0.21% | 9,282,597 +1,070,605 | +13% | +$61M |
|